ARTLVSNIVF• 3 Months (Normalized)
ARTL vs NIVF (Artelo Biosciences Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
-54.55%
Artelo Biosciences Inc.
Normalized Baseline0.00%
NIVF Performance $0.59
+%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin NIVF LEADS
-54.55 pts
NIVF outperforming by 54.55 percentage points
ARTLNIVF
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(60 dates)
| Date | ARTL Price | ARTL Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.54 | -54.55% | $- | - | |
| Sep 24, 2026 | $5.17 | -48.25% | $- | - | |
| Sep 23, 2026 | $7.31 | -26.83% | $0.59 | -85.78% | +58.95% |
| Sep 22, 2026 | $4.15 | -58.46% | $0.73 | -82.32% | +23.86% |
| Sep 21, 2026 | $4.10 | -58.96% | $0.72 | -82.65% | +23.69% |
| Sep 18, 2026 | $3.94 | -60.56% | $0.72 | -82.67% | +22.11% |
| Sep 17, 2026 | $3.97 | -60.26% | $0.72 | -82.77% | +22.51% |
| Sep 16, 2026 | $3.75 | -62.46% | $0.79 | -81.08% | +18.62% |
| Sep 15, 2026 | $5.34 | -46.55% | $0.84 | -79.75% | +33.20% |
| Sep 14, 2026 | $4.87 | -51.25% | $0.93 | -77.61% | +26.36% |
| Sep 11, 2026 | $5.43 | -45.65% | $1.06 | -74.45% | +28.80% |
| Sep 10, 2026 | $5.63 | -43.64% | $1.11 | -73.25% | +29.61% |
| Sep 09, 2026 | $5.98 | -40.14% | $1.10 | -73.49% | +33.35% |
| Sep 08, 2026 | $6.19 | -38.04% | $1.11 | -73.25% | +35.21% |
| Sep 04, 2026 | $6.04 | -39.54% | $1.14 | -72.52% | +32.98% |
Page 1 of 4